IFP Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-864
Closed -$9K 3818
2022
Q4
$9K Buy
864
+434
+101% +$4.36K ﹤0.01% 3448
2022
Q3
$5K Buy
430
+4
+0.9% +$45 ﹤0.01% 4031
2022
Q2
$5K Hold
426
﹤0.01% 3784
2022
Q1
$5K Buy
+426
New +$5.43K ﹤0.01% 3784
2019
Q1
$0 Hold
83
﹤0.01% 2771
2018
Q4
$1K Sell
83
-5,800
-99% -$59.6K ﹤0.01% 3307
2018
Q3
$65K Hold
5,883
﹤0.01% 1745
2018
Q2
$59K Hold
5,883
﹤0.01% 1820
2018
Q1
$61K Hold
5,883
﹤0.01% 1696
2017
Q4
$61K Buy
5,883
+814
+16% +$8.12K ﹤0.01% 1713
2017
Q3
$51K Sell
5,069
-30
-0.6% -$312 ﹤0.01% 1979
2017
Q2
$55K Buy
5,099
+374
+8% +$3.89K ﹤0.01% 1903
2017
Q1
$47K Hold
4,725
﹤0.01% 1965
2016
Q4
$45K Sell
4,725
-298
-6% -$2.9K ﹤0.01% 1950
2016
Q3
$52K Buy
5,023
+298
+6% +$3.26K ﹤0.01% 1784
2016
Q2
$50K Buy
4,725
+4,642
+5,593% +$47.8K ﹤0.01% 1763
2016
Q1
$0 Sell
83
-4,417
-98% -$42.2K ﹤0.01% 2794
2015
Q4
$46K Buy
+4,500
New +$45.6K ﹤0.01% 1669

Other funds holding GRX

IFP Advisors's GRX Position: Q1 2023 in Review

IFP Advisors sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q1 2023, closing a stake of 864 shares — an estimated $9K sold.

IFP Advisors first reported a position in GRX in Q4 2015 and held it in 18 quarters. The position peaked at $65K in Q3 2018. 69 funds tracked by Wall St. Rank hold GRX as of Q1 2023.

  • IFP Advisors reported no remaining Gabelli Healthcare & Wellness Trust position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 864 Gabelli Healthcare & Wellness Trust shares in Q1 2023, an estimated $9K.
  • IFP Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q4 2015 and held it in 18 quarters.
  • IFP Advisors's Gabelli Healthcare & Wellness Trust position peaked at $65K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.